Allstate Corporation’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Buy
256,773
+67,814
+36% +$7.83M 0.33% 44
2025
Q4
$19.9M Buy
188,959
+98,204
+108% +$9.22M 0.27% 51
2025
Q3
$7.62M Buy
90,755
+86,414
+1,991% +$7.12M 0.17% 58
2025
Q2
$344K Sell
4,341
-81,882
-95% -$6.51M 0.02% 112
2025
Q1
$7.74M Buy
86,223
+10,927
+15% +$1.02M 0.23% 50
2024
Q4
$7.49M Buy
75,296
+72,987
+3,161% +$7.52M 0.22% 46
2024
Q3
$262K Sell
2,309
-6,205
-73% -$737K 0.02% 93
2024
Q2
$1.05M Buy
8,514
+5
+0.1% +$644 0.09% 75
2024
Q1
$1.12M Buy
8,509
+110
+1% +$13.6K 0.08% 72
2023
Q4
$916K Sell
8,399
-185
-2% -$19.2K 0.06% 72
2023
Q3
$884K Hold
8,584
0.05% 75
2023
Q2
$991K Hold
8,584
0.06% 71
2023
Q1
$913K Sell
8,584
-100,418
-92% -$10.8M 0.07% 71
2022
Q4
$12.1M Buy
109,002
+1,160
+1% +$119K 0.37% 40
2022
Q3
$9.29M Sell
107,842
-636
-0.6% -$56.8K 0.27% 51
2022
Q2
$9.89M Sell
108,478
-239
-0.2% -$21.2K 0.3% 46
2022
Q1
$8.92M Sell
108,717
-116,330
-52% -$9.17M 0.24% 53
2021
Q4
$17.2M Buy
225,047
+175,608
+355% +$14M 0.33% 48
2021
Q3
$3.71M Sell
49,439
-3,771
-7% -$287K 0.15% 59
2021
Q2
$4.14M Sell
53,210
-2,004
-4% -$149K 0.14% 58
2021
Q1
$4.06M Sell
55,214
-7,192
-12% -$531K 0.13% 67
2020
Q4
$4.87M Sell
62,406
-10,319
-14% -$789K 0.15% 49
2020
Q3
$5.76M Sell
72,725
-9,264
-11% -$726K 0.19% 37
2020
Q2
$6.05M Sell
81,989
-24,520
-23% -$1.85M 0.21% 37
2020
Q1
$7.82M Sell
106,509
-156,062
-59% -$12.3M 0.31% 27
2019
Q4
$22.8M Sell
262,571
-25
-0% -$2.05K 0.41% 29
2019
Q3
$21.1M Buy
262,596
+23
+0% +$1.84K 0.36% 29
2019
Q2
$21M Buy
262,573
+7
+0% +$536 0.38% 32
2019
Q1
$20.8M Sell
262,566
-439
-0.2% -$32.8K 0.56% 25
2018
Q4
$19.2M Buy
+263,005
New +$18.6M 0.63% 23
2017
Q3
Sell
-57,671
Closed -$3.53M 175
2017
Q2
$3.53M Sell
57,671
-3,009
-5% -$183K 0.19% 40
2017
Q1
$3.68M Sell
60,680
-71,508
-54% -$4.34M 0.22% 63
2016
Q4
$7.43M Buy
132,188
+32,626
+33% +$1.91M 0.44% 68
2016
Q3
$5.93M Sell
99,562
-26,837
-21% -$1.57M 0.42% 41
2016
Q2
$6.95M Sell
126,399
-23,084
-15% -$1.23M 0.45% 56
2016
Q1
$7.55M Buy
149,483
+60,291
+68% +$2.95M 0.65% 57
2015
Q4
$4.5M Buy
89,192
+14,696
+20% +$741K 0.43% 61
2015
Q3
$3.51M Sell
74,496
-1,613
-2% -$85.7K 0.36% 68
2015
Q2
$4.13M Sell
76,109
-35,454
-32% -$1.99M 0.37% 66
2015
Q1
$6.12M Sell
111,563
-51,486
-32% -$2.92M 0.51% 47
2014
Q4
$8.84M Sell
163,049
-82,227
-34% -$4.58M 0.68% 25
2014
Q3
$13.9M Sell
245,276
-133,164
-35% -$7.48M 0.63% 23
2014
Q2
$20.9M Buy
378,440
+122,570
+48% +$6.69M 0.56% 30
2014
Q1
$13.9M Buy
255,870
+99,753
+64% +$5.17M 0.45% 53
2013
Q4
$7.46M Buy
156,117
+33,686
+28% +$1.54M 0.28% 87
2013
Q3
$5.56M Hold
122,431
0.22% 104
2013
Q2
$5.43M Buy
+122,431
New +$5.47M 0.25% 97

Other funds holding MRK

Allstate Corporation's MRK Position: Q1 2026 in Review

Allstate Corporation increased its Merck (MRK) stake by 36% in Q1 2026, buying an estimated $7.83M and bringing the position to 256,773 shares worth $30.9M. The position accounts for 0.33% of the portfolio, ranked #44.

Allstate Corporation first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Allstate Corporation held 256,773 shares of Merck worth $30.9M as of Q1 2026.
  • Allstate Corporation bought 67,814 Merck shares in Q1 2026, an estimated $7.83M.
  • Merck made up 0.33% of Allstate Corporation's portfolio in Q1 2026, its #44 holding.
  • Allstate Corporation first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.